Skip to content
AASLD Family of Websites: Liver Fellow Network
AASLD.org AASLD Foundation LiverLearning Career Center Journals The Liver Meeting HCV Guidelines
AASLD Logo
AASLD Logo

LFN Main Navigation

  • Topics
    Acute Liver Failure Alcohol-Associated Liver Disease Autoimmune Hepatitis Career Development and Mentorship Cholestatic Liver Disease Complications of Liver Disease and Portal Hypertension Drug-Induced Liver Disease HepMadness Inherited Disorders Liver Anatomy, Development, and Physiology Liver Infections Liver Physiology Liver Related Infections MASLD/MASH Neoplasms of the Liver Pathology Pediatrics Pregnancy-Related Liver Disease Symptoms and Clinical Presentation of Liver Disease and Portal HTN Systemic Conditions with Hepatic Manifestations Transplantation and Surgery Vascular Viral Hepatitis
  • Core Series
    Back to Basics Clinical Pearls Webinars Evidence Corner Pathology Pearls Podcast The Why? Series Tools of the Trade View All Core Series Practice Questions
  • Tweetorials
  • About
  • Core Series
  • Evidence Corner
  • What Is MELD 3.0 And How Might It Better Predict Waitlist Mortality Than MELD-Na?

What is MELD 3.0 and how might it better predict waitlist mortality than MELD-Na?

May 8, 2022

Nabeel Wahid

Share

Copy Link Twitter Facebook

Heard about MELD 3.0 but not sure how it differs from MELD-Na? This is the paper that explains what MELD 3.0 is and how it came to be. https://www.gastrojournal.org/article/S0016-5085(21)03469-7/fulltext

Transplantation and Surgery

Share

Copy Link Twitter Facebook

Written By:

Nabeel Wahid

Gastroenterology Fellow, Northwestern University

Related Content

Is a transplant benefit-based allocation for deceased donor livers feasible ?

March 3, 2025

Targeted Nasogastric Feeding Improves Muscle Function in Liver Transplant Candidates with Severe Malnutrition

October 7, 2024

Evidence Corner: Impact of Normothermic Regional Perfusion in a National Cohort of DCD Liver Transplants

January 15, 2024

AASLD LFN Logo

Follow Us

Disclaimer & Privacy Policy

© 2025 American Association for the Study of Liver Diseases